Myeloma is the 17th most common cause of cancer death in the UK, accounting for 2% of all cancer deaths (2017).[1-3]
In females in the UK, myeloma is the 16th most common cause of cancer death (2% of all female cancer deaths). In males in the UK it is the 16th most common cause of cancer death (2% of all male cancer deaths).
44% of myeloma deaths in the UK are in females, and 56% are in males.
Myeloma mortality rates (European age-standardised
Myeloma (C90), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2017
|AS Rate - 95% LCL||3.8||2.9||2.6||2.5||3.8|
|AS Rate - 95% UCL||4.3||4.3||4.3||5.2||4.2|
|AS Rate - 95% LCL||6.0||6.1||4.1||4.4||6.0|
|AS Rate - 95% UCL||6.6||8.3||6.4||8.2||6.6|
|AS Rate - 95% LCL||4.8||4.5||3.5||3.8||4.8|
|AS Rate - 95% UCL||5.2||5.8||5.0||6.0||5.2|
- Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
- Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
- Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2017, ICD-10 C90.